-transparent.png){kind=logo}
Ticlopidine hydrochloride 180 mg was given orally to rabbits and OKY-046 50 mg was simultaneously administered intravenously. Ticlopidine inhibited the platelet aggregation induced by ADP when the Ticlopidine was orally administered separately, but the platelet aggregation induced by PAF, collagen and arachidonic acid (A.a.) was not significantly decreased. Simultaneous administration of Ticlopidine and OKY-046, as compared to administration of Ticlopidine alone, led to a significant decrease in the platelet aggregation induced by A.a. and collagen. The simultaneous administration did not give rise to an additive or synergistic effect on the platelet aggregation induced by ADP.
T Kosugi, and
M Nakamura, and
S Saitoh, and
K Kinjoh
January 1983,
Thrombosis research. Supplement,
T Kosugi, and
M Nakamura, and
S Saitoh, and
K Kinjoh
June 1986,
Thrombosis and haemostasis,
T Kosugi, and
M Nakamura, and
S Saitoh, and
K Kinjoh
September 1992,
Minerva medica,
T Kosugi, and
M Nakamura, and
S Saitoh, and
K Kinjoh
October 1980,
Thrombosis research,
T Kosugi, and
M Nakamura, and
S Saitoh, and
K Kinjoh
October 1989,
Japanese journal of pharmacology,
T Kosugi, and
M Nakamura, and
S Saitoh, and
K Kinjoh
June 1986,
Thrombosis and haemostasis,
T Kosugi, and
M Nakamura, and
S Saitoh, and
K Kinjoh
May 1986,
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
T Kosugi, and
M Nakamura, and
S Saitoh, and
K Kinjoh
February 1986,
Prostaglandins, leukotrienes, and medicine,
T Kosugi, and
M Nakamura, and
S Saitoh, and
K Kinjoh
August 1999,
The Journal of surgical research,
T Kosugi, and
M Nakamura, and
S Saitoh, and
K Kinjoh
December 1984,
Prostaglandins,
